Skip to content

Our Company
Our Focus
Our Science
Our Medicines
Our Advocacy
- Forward Together
Join The Team
For Media
Contact Us
Twitter
LinkedIn
Instagram

Pipeline

Relugolix Combination Tablet

MVT-602

Board of Directors

Documents & Charters

Committee Composition

Expanded Access

Author: Cognition Studio

Our Company

Our Purpose
Our Leadership
Our Locations

Our Focus

The Problem
Uterine Fibroids
Endometriosis
Prostate Cancer
Infertility

Our Science

Pipeline
Relugolix Combination Tablet
MVT-602

Our Medicines

Our Advocacy

Forward Together

Join the Team

Our Culture
Our Benefits
Open Positions

For Media

Press Releases
Events
Presentations
Corporate Governance
Expanded Access

Contact Us

© 2023 Myovant Sciences GmbH. All rights reserved.

Terms of Use
Privacy Policy
Cookie Policy
SMS Terms & Conditions
Compliance & Prescriber Information

Uterine Fibroids

Prostate Cancer

Relugolix Combination Tablet

Forward Together

INVESTORS & MEDIA

Company Overview

Stock Information

Financials & Filings

Corporate Governance

OUR COMPANY
OUR FOCUS
OUR SCIENCE
OUR MEDICINES
OUR ADVOCACY
- Forward Together
JOIN THE TEAM
INVESTORS & MEDIA
CONTACT US
TWITTER
LINKEDIN
Instagram